For entrepreneurs and early stage companies, raising capital can be challenging. For female entrepreneurs it can be even more challenging as they can experience gender bias in their efforts to [….]
Expanding the mechanisms for administering therapeutics and vaccines may have the potential to disrupt the status quo and improve availability and accessibility of therapeutic and preventive treatments. This session will [….]
In seeking to combat emerging infectious diseases and other 21st-century health threats, the path to better prepared, protected, and healthy individuals, families, and communities could rely on unlocking the collective power of the global community. BLUE KNIGHT™ seeks to answer this call.
Approximately 300,000 children from infancy to age 14 are diagnosed with cancer worldwide every year [1]. Although cure rates for some pediatric cancers have increased to about 80% in recent [….]
National Capital Consortium for Pediatric Device Innovation (NCC-PDI) Announces Virtual Pediatric Pitch Competition Winners The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) recently announced the winners of its annual [….]
As the COVID-19 pandemic continues to spread across the world, reports on the unique experience of COVID-19 in children are starting to emerge. Most recently, a rare, but serious condition [….]
In Conversation: Sally Allain, Head, JLABS @ Washington, DC – Johnson & Johnson Innovation BioBuzz recently caught up with the Head of JLABS @ Washington, DC, Sally Allain, to discuss [….]
